Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 14,020 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 22.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,885 shares of the company's stock after buying an additional 14,020 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.23% of The Pennant Group worth $2,066,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of PNTG. Voloridge Investment Management LLC acquired a new position in shares of The Pennant Group during the 4th quarter worth $1,282,000. Zimmer Partners LP bought a new stake in shares of The Pennant Group during the 4th quarter valued at about $3,978,000. Squarepoint Ops LLC purchased a new stake in shares of The Pennant Group in the fourth quarter worth approximately $398,000. Two Sigma Advisers LP lifted its holdings in The Pennant Group by 144.8% during the fourth quarter. Two Sigma Advisers LP now owns 131,700 shares of the company's stock worth $3,493,000 after acquiring an additional 77,900 shares during the period. Finally, Two Sigma Investments LP increased its position in The Pennant Group by 192.8% in the fourth quarter. Two Sigma Investments LP now owns 154,818 shares of the company's stock worth $4,106,000 after buying an additional 101,943 shares during the last quarter. Institutional investors and hedge funds own 85.88% of the company's stock.

Insider Buying and Selling at The Pennant Group

In other The Pennant Group news, Director Joanne Stringfield sold 5,000 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the sale, the director now directly owns 30,275 shares of the company's stock, valued at $892,204.25. The trade was a 14.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 5.40% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PNTG shares. Wells Fargo & Company lifted their price target on The Pennant Group from $30.00 to $31.00 and gave the company an "equal weight" rating in a research report on Tuesday, June 3rd. Truist Financial lifted their price objective on The Pennant Group from $28.00 to $32.00 and gave the company a "hold" rating in a research note on Monday, May 12th. Finally, Stephens reissued an "overweight" rating and set a $35.00 price objective on shares of The Pennant Group in a research note on Tuesday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $34.60.

Read Our Latest Stock Report on The Pennant Group

The Pennant Group Stock Down 2.5%

NASDAQ PNTG traded down $0.70 during trading on Wednesday, reaching $27.65. 375,635 shares of the company's stock were exchanged, compared to its average volume of 225,210. The company has a 50 day moving average price of $27.21 and a two-hundred day moving average price of $26.82. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The Pennant Group, Inc. has a 1 year low of $21.18 and a 1 year high of $37.13. The stock has a market cap of $953.07 million, a P/E ratio of 40.66, a price-to-earnings-growth ratio of 2.24 and a beta of 1.51.

About The Pennant Group

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines